Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|12|1782-1789

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.12, 2011-11, pp. : 1782-1789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasminogen Activator Inhibitor-1

By  

Current Medicinal Chemistry, Vol. 11, Iss. 17, 2004-09 ,pp. : 2323-2334

Bentham Science Publishers

Access to resources Recommend Favorite

The status of plasminogen activator inhibitor-1

By Charlton P.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. : 539-554

Informa Healthcare

Access to resources Recommend Favorite

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

By Orio Francesco   Palomba Stefano   Cascella Teresa   Tauchmanovà Libuse   Nardo Luciano G.   Di Biase Sebastiano   Labella Donato   Russo Tiziana   Savastano Silvia   Tolino Achille   Zullo Fulvio   Colao Annamaria   Lombardi Gaetano  

Reproductive BioMedicine Online, Vol. 10, Iss. 2, 2005-02 ,pp. : 289-292

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

By Orio Francesco   Palomba Stefano   Cascella Teresa   Tauchmanovà Libuse   Nardo Luciano G   Di Biase Sebastiano   Labella Donato   Russo Tiziana   Savastano Silvia   Tolino Achille   Zullo Fulvio   Colao Annamaria   Lombardi Gaetano  

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 505-510

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in rats - II. Effects on hemostasis, thrombosis and thrombolysis

By Ohtani A.   Murakami J.   Hirano-Wakimoto A.  

European Journal of Pharmacology, Vol. 330, Iss. 2, 1997-07 ,pp. : 151-156

Elsevier

Access to resources Recommend Favorite